A Multicentre Hospital Study to Compare the Hypnotic Efficacy of Loprazolam and Nitrazepam
| Autor: | Catherine S C Elliott, S I Ankier, C Joan McAlpine |
|---|---|
| Rok vydání: | 1984 |
| Předmět: |
Adult
Male Adolescent Nitrazepam medicine.drug_class 030204 cardiovascular system & hematology Placebo Biochemistry Hypnotic Benzodiazepines 03 medical and health sciences 0302 clinical medicine Sleep Initiation and Maintenance Disorders medicine Insomnia Humans Wakefulness Aged Morning Psychomotor learning Benzodiazepinones Clinical Trials as Topic business.industry Biochemistry (medical) Cell Biology General Medicine Middle Aged Alertness Anti-Anxiety Agents 030220 oncology & carcinogenesis Anesthesia Female Sleep Stages medicine.symptom Loprazolam business medicine.drug |
| Zdroj: | Journal of International Medical Research. 12:229-237 |
| ISSN: | 1473-2300 0300-0605 |
| DOI: | 10.1177/030006058401200402 |
| Popis: | A multicentre, parallel group hospital study was carried out in 190 subjects with insomnia to compare the efficacy, incidence of hangover and the side-effects of loprazolam and nitrazepam. Following 2 nights single-blind phase on placebo, loprazolam (1·0 mg), nitrazepam (5·0 mg) or placebo was administered double-blind for 7 consecutive nights. Visual analogue scales and questions were used to rate efficacy. There was no statistically significant difference between loprazolam and nitrazepam for ‘ease of getting to sleep’, ‘restfulness of sleep’ and ‘depth of sleep’. Like nitrazepam, loprazolam diminished the number of periods of wakefulness and made it ‘easier to get to sleep again’. Subjective evaluation showed that hangover was not a feature of loprazolam. It did not affect morning alertness and patients thought they had improved balance and co-ordination while on this drug. These findings are in keeping with the evidence of other workers who have shown only minimal psychomotor impairment, if any, with loprazolam (1·0 mg). There was no statistically significant difference between treatments with respect to frequency or incidence of side-effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|